Yongan pharmaceutical products will be prosecuted in the United States work related to preparations-roxane hayward

Yongan pharmaceutical products being sued will actively prepare the respondent hot column capital flows thousand thousand shares of stock on the latest rating diagnosis simulated trading client App Sina Finance in the United States: Live on-line bloggers to tutor you say stocks contest 60 million, reporter Zhu Wenbin Qiu Jiang, editor of Yongan pharmaceutical disclosed today, companies from the United States Puying LLP Shanghai representative office was informed that the company in the United States District Court for the District of New Jersey for alleged patent infringement prosecution. The plaintiff claimed that the taurine products of Yongan pharmaceutical industry violated its "450 patent" and "patent of 451" in the United states. The plaintiff requests the court, constitute infringement, and request a permanent ban, all individuals, and the defendant or the defendant related entities involved, and the defendant against the defendant to the abuse of patent right and patent 450 "or" 451 patent ", and cut the amount of certain damage compensation, including the ability to fully compensate for the infringement by the defendant act of the damage compensation, pre judgment interest and litigation costs etc.. At present, Yongan has not yet received formal litigation document of the judiciary, but based on the principle of prudence, will actively prepare the respondent. Data show that taurine is widely used in foreign countries, such as functional beverages, infant formula, drugs, pet food and feed and other fields. As the world’s largest supplier of taurine and international, Yongan pharmaceutical market share of the global market as high as 50%. It is understood that the company taurine products 80% for export. Annual data show that in recent years, the main component of taurine in Yongan pharmaceutical occupy an increasingly important position. As a result, the company admitted that, if lost, may have an important impact on the company. THE_END to enter [Sina financial stocks] discussion相关的主题文章:

« »

Comments closed.